Breakthrough Tracker record
Human pituitary organoids produced transient hormone responses in a primate model
Kondo and collaborators transplanted human pluripotent-stem-cell-derived pituitary–hypothalamus organoids into mice and one cynomolgus monkey. The primate showed increased ACTH and cortisol for about six weeks before function waned as inflammatory rejection emerged.
← Back to the filtered Breakthrough Tracker
- Stable ID
medicine-pituitary-organoid-primate-2026- Revision
medicine-pituitary-organoid-primate-2026.v1- Field
- Medicine and biology · Regenerative medicine, endocrinology and organoid transplantation
- Evidence
- Tier 1 · Peer reviewed: Yes
- Record state
- Current · Peer-reviewed preclinical result
- Last checked
AI role
No substantive AI role was disclosed in the inspected primary article or institutional account.
Record details
- Problem or result
- Functional pituitary-cell replacement beyond rodents
- Authors
- Tatsuma Kondo, Hidetaka Suga, Kenji Watari, Shiori Taga and collaborators
- Institutions
- Nagoya University with collaborating academic and industry researchers
- Result date
- Published October 2, 2026
Why it matters
The study moves pituitary replacement from rodents to a functional large-animal feasibility test and shows that the graft can temporarily engage an intact adrenal axis.
Limits
The primate evidence is one uncontrolled xenograft with short follow-up, intensive immunosuppression and eventual rejection. It establishes neither human safety nor durable efficacy, dosing, tumour safety or a clinical treatment.
Sources
- Primary: Stem Cell Research & Therapy, pituitary-organoid transplantation
- Institutional: Nagoya University release on the pituitary-organoid study
Correction and revision history
- 2026-10-05 — Added after primary-source, scope, status, AI-role and limitation review.
Machine-readable: JSON v1 · CSV v1 · Schema v1
This individual record remains noindex until a story-specific featured image passes Kingy’s rendered-pixel visual review. The source-linked tracker hub remains the public index.